Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Insilico Medicine Announces First-in-Human Study for Orally PHD Inhibitor ISM5411 for Inflammatory Bowel Disease (IBD) 2023-12-05 06:00
CARsgen's CT071 Received IND Clearance from the FDA for Treating Relapsed/Refractory Multiple Myeloma or Relapsed/Refractory Primary Plasma Cell Leukemia 2023-12-04 21:50
Technoderma Medicines Completes Phase 1 Dose Escalation Clinical Trial of TDM-180935 for Atopic Dermatitis 2023-12-04 21:13
Abbisko Therapeutics Announced the Entry into a Licensing Agreement for Pimicotinib (ABSK021) with Merck 2023-12-04 21:05
Crystal Pharmatech's CDMO Business Unit successfully passed the dual certification of GMP and GDP conducted by SGS 2023-12-04 21:00
Latest Updates of Viva's Portfolio Companies 2023-12-04 17:55
First Patient Dosed in Phase Ⅲ Study of JSKN003 for the Treatment of Advanced HER2-Low Breast Cancer 2023-12-04 14:51
Nona Biosciences Announces Collaboration Agreement with Lycia Therapeutics 2023-12-04 13:19
First Patient Dosed in European Named Patient (Early Access) Program for TLX250-CDx, Telix's Kidney Cancer Imaging Agent 2023-12-04 13:00
Everest Medicines Announces Investigational New Drug Application Acceptance of Zetomipzomib in China 2023-12-04 08:58
The Shanghai Cooperation Organization Traditional Medicine Forum opened 2023-12-01 17:49
Sirnaomics Promotes Francois Lebel, M.D. to Chief Medical Officer 2023-12-01 14:41
Innovent Presents Clinical Data Update of IBI351 (KRAS G12C Inhibitor) Monotherapy in Lung Cancer and Colorectal Cancer at ESMO Asia Congress 2023 2023-12-01 12:00
CNN's 'Vital Signs' explores the prospects of phage therapy to treat drug-resistant superbugs 2023-12-01 11:29
Everest Medicines Announces Positive Topline Results from Induction Period of Etrasimod Phase 3 Clinical Trial Conducted in Asia for the Treatment of Moderate-to-Severe Active Ulcerative Colitis 2023-12-01 07:33
Bushu Pharma Recognized with Frost & Sullivan's 2023 Japan Customer Value Leadership Award for Offering Advanced Pharmaceutical Manufacturing and Robust Supply Chain Solutions 2023-11-30 22:30
Registrational Phase III CLARIFY trial in prostate cancer commences 2023-11-30 22:16
First patient with metastatic prostate cancer to receive 2 doses of Cu-67 SAR-bisPSMA achieves undetectable PSA level 2023-11-30 21:59
Innovent's MSCI ESG Rating Upgraded to A 2023-11-30 21:37
Peptone and The Institute of Oncology Research (IOR) Bellinzona Announce Collaborative Research Agreement 2023-11-30 20:00
1 64 65 66 67 68 413